Premium
Long‐term remission of recalcitrant tumour‐stage mycosis fungoides following chemotherapy with pegylated liposomal doxorubicin
Author(s) -
Tsatalas C,
Martinis G,
Margaritis D,
Spanoudakis E,
Kotsianidis I,
Karpouzis A,
Bourikas G
Publication year - 2003
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1046/j.1468-3083.2003.00642.x
Subject(s) - mycosis fungoides , medicine , stage (stratigraphy) , chemotherapy , doxorubicin , oncology , dermatology , surgery , lymphoma , paleontology , biology
Advanced stage mycosis fungoides (MF) generally has a poor prognosis, and currently there is no standard treatment available. Here we report the case of a young woman with recalcitrant tumour‐stage MF (T3, stage IIb) whose disease was unresponsive to several therapeutic modalities, but who has showed sustained clinical response to pegylated liposomal doxorubucin. No severe infectious complications have been observed. The use of this drug in tumour‐stage MF should be investigated further.